Miami, FL – (March 8, 2012) – Modern Veterinary Therapeutics, LLC announces today that the Australian Pesticides and Veterinary Medicines Authority (APVMA) has approved CEPESEDAN, CEPETOR and REVERTOR in Australia. CEPESEDAN (detomidine) is indicated for use as a sedative and analgesic to facilitate minor surgical and diagnostic procedures in mature horses and yearlings. The product is presented in 5ml and 20ml vials. CEPETOR (medetomidine) is indicated for use as sedative and analgesic to facilitate clinical examinations, clinical procedures, minor surgical procedures in dogs and cats. The product is presented in 10ml vial. REVERTOR (atipamezole) is indicated for the reversal of the clinical effects of the sedative and analgesic agent, medetomidine hydrochloride in dogs and cats. The product is presented in 10ml vial. These three products will be presented and featured at the Australian Veterinary Association (AVA) Annual Conference 2012 in May in Canberra at the National Convention Center on May 20-25. “As we continue our aggressive global expansion strategy, Modern Veterinary Therapeutics is very excited to be entering the Australian market with our pharmaceutical product line.” Said Dr. Cuong Tu Ba, Founder and President of Modern Veterinary Therapeutics, LLC.